Skip to main content
Lumax Industries Ltd. logo

Lumax Industries Ltd. — Investor Relations & Filings

Ticker · LUMAXIND ISIN · INE162B01018 LEI · 3358008JDWZOMX8S3L98 BSE.NS Manufacturing
Filings indexed 2,035 across all filing types
Latest filing 2026-04-14 Regulatory Filings
Country IN India
Listing BSE.NS LUMAXIND

About Lumax Industries Ltd.

https://www.lumaxindustries.com

Lumax Industries Ltd. specializes in the design, development, and manufacturing of advanced automotive lighting systems. As a flagship entity of the Lumax-DK Jain Group, the company maintains a long-standing technical and financial collaboration with Stanley Electric Co. Ltd., Japan. Its product portfolio encompasses a comprehensive range of lighting solutions, including headlamps, rear combination lamps, fog lamps, and auxiliary lighting for passenger vehicles, two-wheelers, commercial vehicles, and agricultural equipment. The company operates multiple state-of-the-art manufacturing facilities and dedicated research and development centers focused on integrating cutting-edge LED technologies and electronics into automotive illumination. Lumax serves as a primary supplier to major original equipment manufacturers (OEMs), emphasizing high-quality standards, innovation in optical design, and the transition toward energy-efficient lighting solutions.

Recent filings

Filing Released Lang Actions
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended March 31, 2026
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialisation of shares for the quarter ended March 31, 2026. It is a compliance certificate from the Registrar and Share Transfer Agent to the stock exchanges and depositories. The document is short (3483 characters) and serves as a regulatory compliance filing rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and miscellaneous regulatory announcements that do not fit other categories.
2026-04-14 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialisation of shares for the quarter ended March 31, 2026. It is a compliance certificate from the Registrar and Share Transfer Agent to stock exchanges and depositories. The document is short (3483 characters) and serves as a regulatory compliance filing rather than a financial report or detailed analysis. It does not contain financial statements or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and miscellaneous regulatory announcements.
2026-04-14 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 85% confidence The document is a mandated disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, addressed to stock exchanges and the audit committee. It is a compliance/certification statement about share encumbrances rather than a change in shareholding threshold, financial results, or management/board changes. It does not contain substantive financial statements or present an annual report, interim report, or investor presentation. Therefore, it best fits the fallback category for general regulatory compliance filings.
2026-04-07 English
Intimation for Closure of Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges regarding the closure of the trading window for insiders ahead of the announcement of audited financial results for the quarter and financial year ending March 31, 2026. It references compliance with insider trading regulations and states that the date of the board meeting to approve the results will be intimated later. The document is short (2184 characters) and does not contain any financial data or the results themselves, only an announcement about the trading window closure related to upcoming financial results. This fits the profile of a Regulatory Filing (RNS) as it is a compliance-related announcement and not the financial report itself or a detailed report publication announcement.
2026-03-27 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the closure of the trading window for insiders ahead of the announcement of audited financial results for the quarter and financial year ending March 31, 2026. It references compliance with insider trading regulations and states that the date of the board meeting to approve the audited results will be intimated later. The document does not contain any financial data or the actual financial results but is an announcement related to the timing of trading restrictions before the financial results are published. The document length is short (2184 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2026-03-27 English
Reply to Clarification- Financial results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited's Surveillance Team regarding a submission of a revised XBRL filing for financial results for the quarter and nine months ended December 31, 2025. It clarifies a clerical error in the XBRL data entry related to the Profit Before Tax figure and confirms that the PDF results remain accurate. The document is short (1731 characters) and primarily serves as a correction and submission notice of revised financial data rather than containing the full financial report itself. It does not contain actual financial statements or substantive financial data and analysis but is an update related to regulatory filing compliance. Therefore, it fits best under Regulatory Filings (RNS) as a miscellaneous regulatory announcement and correction notice rather than an Interim/Quarterly Report (IR) or Annual Report (10-K).
2026-03-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.